Comparison of the predictive value of three risk assessment tools on the chemotherapy-induced nausea and vomiting
10.3969/j.issn.1673-9701.2024.14.008
- VernacularTitle:三种急性化疗相关性恶心呕吐预测工具的比较
- Author:
Xiaoxue WEN
1
;
Cuiying ZHANG
;
Li ZHU
;
Li TAO
;
Lizhen CHEN
;
Xinyan YU
Author Information
1. 浙江省肿瘤医院 中国科学院杭州医学研究所 肝胆胰胃肿瘤内科,浙江杭州 310022
- Keywords:
Tumor;
Chemotherapy-induced nausea and vomiting;
Risk assessment;
Predictive value
- From:
China Modern Doctor
2024;62(14):33-36
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the comparison of the predictive value of three risk assessment tools on the chemotherapy-induced nausea and vomiting(CINV)in cancer patients.Methods From January 2022 to December 2022,convenience sampling was used to select 626 cancer patients with Intravenous chemotherapy in the Department of Hepatobiliary Pancreatic Oncology of Zhejiang Cancer Hospital as the research object.CINV risk assessment of patients was performed using George teams acute CINV prediction tool,Dranitsari's CINV risk assessment and CINV nomogram model.Area under curve(AUC),sensitivity,specificity and Youden index were used to compare the predictive value of the three tools.Results Totally 622 patients were ultimately included in the study,with an overall effective rate of 99.36%.There were 51.13%(318/622)patients who experienced CINV.Specifically,patients with grade 2 or higher acute CINV accounted for 18.17%(113/622).When using the three tools for acute CINV risk assessment,the AUC was respectively 0.591,0.616 and 0.558.And Dranitsari's CINV risk assessment has the highest sensitivity,acute and delayed chemotherapy-induced nausea and vomiting prediction tool has the highest specificity.Comparatively,Dranitsari's CINV risk assessment on the Yorden index is better.Conclusion The incidence of CINV in cancer patients is at a high level.The three tools can not effectively predict the risk of acute CINV.We need to develop a localized,multi-disease,standardized CINV risk assessment model for hospital.
